Skin & hair

Does Basal Cell Carcinoma Spread? What Actually Happens

Save

The question behind this search is usually fear that a small skin cancer is quietly seeding elsewhere. For basal cell carcinoma, that is the wrong fear. It is a very common skin cancer, and its behavior is stubbornly local: it enlarges and invades nearby tissue, but it rarely metastasizes. This page explains what spread means for basal cell, how it is removed, and how quickly a suspicious spot should be seen.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Does basal cell carcinoma spread to other parts of the body?

Rarely. Basal cell carcinoma is the least likely of the common skin cancers to travel through the lymph nodes or bloodstream to distant organs — metastasis is genuinely uncommon. Its danger is not that it spreads far, but that it keeps growing where it started, invading and destroying the tissue immediately around it when it is left untreated. Clinicians remove it with a margin of normal-looking tissue precisely because it advances locally rather than because they expect it to seed elsewhere 1.

Metastasis means cancer cells breaking away to start a new tumor in a distant organ, and basal cell carcinoma almost never does this. The worry worth having is not distant spread but local growth — what the tumor is doing to the skin, cartilage, or bone right where it sits. A basal cell caught while it is small is treated where it is; one ignored for years is a harder problem for exactly that reason.

What local growth actually looks like

Basal cell carcinoma tends to appear on skin that has seen the most sun — the face, ears, neck, scalp, and the backs of the hands. It grows slowly, over months to years, which is part of why it is so often ignored. Dermatologists recognise several forms, and no two look identical.

The most familiar is a pearly or waxy bump, sometimes with tiny visible blood vessels, that may bleed, scab over, and then reopen — a pearly bump on the face that won't heal is the classic description. Another form is a flat, firm, scar-like patch that appeared on skin with no injury to explain it. A third looks like a red scaly patch that won't go away and is easy to mistake for eczema or a dry spot. None of these can be confirmed by eye, and none can be ruled out by eye either — that is what a biopsy is for.

How basal cell carcinoma is removed

Treatment starts with a biopsy — a small sample of the spot examined under a microscope — because the appearance alone does not settle the diagnosis or the tumor type 1. Once confirmed, most basal cell carcinomas are removed by surgical excision: the visible tumor plus a margin of normal-looking skin is cut out so the edges come back clear 1.

For tumors in high-risk locations — the face, ears, and the skin around the eyes, nose, and lips — or for aggressive, deeply rooted subtypes, Mohs micrographic surgery is often the recommended approach 2. In Mohs, the surgeon removes the tumor one thin layer at a time and checks each layer under the microscope during the same visit, which spares healthy tissue in cosmetically and functionally important areas while confirming the margins are clear 2. Topical creams and photodynamic therapy have a more limited role, generally reserved for certain thin, superficial tumors 1.

Basal cell, squamous cell, and melanoma are not the same question

"Does it spread" has a different answer for each of the three common skin cancers, which is why matching your spot to the wrong one is misleading. Basal cell carcinoma is the least likely to spread. Squamous cell carcinoma sits in the middle: it can spread, which is why clinicians risk-stratify it into low- and high-risk tumors and send high-risk squamous cell carcinoma for Mohs surgery 3. Melanoma is the skin cancer most able to metastasize, and it is staged and treated on a different pathway altogether.

This matters because reassurance about basal cell does not transfer. A spot that turns out to be basal cell is one story; the same-looking spot that turns out to be melanoma is another. That is the honest reason not to settle the question from a description — including this one.

Why basal cell carcinoma develops

The main driver is cumulative ultraviolet exposure — years of sunlight and time in tanning beds damaging the DNA of skin cells 4. That is why basal cell carcinoma clusters on sun-exposed skin, and why avoiding UV radiation, from both the sun and sunlamps, is the prevention that has evidence behind it 4. Fair skin, a history of sunburns, older age, and a weakened immune system all raise the odds.

A different pattern is worth naming: developing multiple basal cell carcinomas at a young age, or a first one unusually early, is something clinicians take seriously and sometimes trace to an inherited condition. It is a reason to mention family history and any earlier skin cancers when you are seen, rather than to treat each spot as an isolated event.

What to do about a spot you think might be basal cell carcinoma

The useful response is the same one this page keeps returning to: document it and get it examined, rather than diagnose it from an article. Photograph the spot in good, even light with a ruler or coin beside it for scale, and note the date. Take another photo in a few weeks. A spot that bleeds and won't heal, that keeps enlarging, or that reopens in the same place after seeming to heal is worth a dermatology visit — those are the changes clinicians want to see, not a verdict you have talked yourself into.

Whether basal cell carcinoma is dangerous depends almost entirely on where it is and how long it has been growing. It rarely threatens life, but on the face it can invade the eyelid, the nose, or the ear and do real functional and cosmetic damage if it is left for years — which is the whole argument for not waiting to be seen. Because it grows slowly, there is usually time to get an appointment; there is rarely a reason to panic, and rarely a reason to postpone indefinitely either.

Common questions

It is possible but very rare. Basal cell carcinoma overwhelmingly stays local, growing into the skin and structures around it rather than travelling to lymph nodes. Spread to nodes or distant organs is reported only in a small number of neglected or unusually aggressive tumors. For almost everyone, the practical concern is local growth, not nodal spread — which is why removal is the standard response.

Usually slowly — over months to years rather than days or weeks. That slow pace is exactly why a basal cell carcinoma is so easy to overlook or dismiss as a spot that will heal on its own. Slow growth is not the same as harmless, though: a tumor left for years can enlarge and invade deeper tissue, so a persistent, non-healing spot is still worth having examined.

Yes, it can recur, either at the original site or as a new basal cell carcinoma elsewhere on sun-exposed skin. Someone who has had one is at higher risk of another, which is why dermatologists often recommend periodic skin checks afterward. Recurrence at the treated site is one reason surgeons aim for clear margins and use Mohs surgery for higher-risk locations.

It keeps growing where it is. Over months and years an untreated basal cell carcinoma can enlarge and invade nearby skin, cartilage, and bone, which on the face can mean damage to the eyelid, nose, or ear. It still rarely metastasizes, but the local destruction can become extensive and harder to repair — the reason clinicians treat it rather than watch it.

For the large majority of people, no. Basal cell carcinoma very rarely spreads to distant organs, so it seldom threatens life the way some cancers do. Its harm is local. The exceptions are tumors neglected for a long time or in people with weakened immune systems, where growth can become aggressive. Even then, the emphasis is on removing it before it does more local damage.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a non-healing spot needs a closer look

  • —A pearly, waxy, or translucent bump that bleeds, scabs, and reopens in the same place over several weeks
  • —A flat, scar-like or waxy patch that is slowly enlarging with no injury to explain it
  • —A sore on the face, ear, or scalp that partly heals and then breaks down again and again
  • —A known or suspected basal cell carcinoma near the eye, nose, or ear that is visibly growing

This article explains what basal cell carcinoma does and how it is treated; it cannot diagnose your spot. Only an in-person exam and, when needed, a biopsy can tell what a lesion is. A dermatologist or clinician can evaluate a changing or non-healing spot.

References

  1. 1.Kim JYS, Kozlow JH, Mittal B, et al. (2018). Guidelines of care for the management of basal cell carcinoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2017.10.006AAD guideline that basal cell carcinoma is diagnosed by biopsy and managed by margin-controlled surgical excision — with topical and photodynamic therapy in a limited role for thin superficial tumors — because it grows by local invasion.
  2. 2.Ad Hoc Task Force (Connolly SM, Baker DR, Coldiron BM, et al.) (2012). AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2012.06.009Multi-society appropriate use criteria supporting Mohs micrographic surgery for basal cell carcinomas in high-risk anatomic locations such as the face and for aggressive histologic subtypes.
  3. 3.Kim JYS, Kozlow JH, Mittal B, et al. (2018). Guidelines of care for the management of cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2017.10.007AAD guideline that cutaneous squamous cell carcinoma is risk-stratified into low- and high-risk tumors, with Mohs micrographic surgery used for high-risk squamous cell carcinoma.
  4. 4.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Skin Cancer Prevention (PDQ®)–Health Professional Version. NIH / National Cancer Institute. link ✓NCI PDQ evidence summary that ultraviolet radiation from sun and tanning beds is a modifiable risk factor for skin cancer and that avoiding UV exposure is the evidence-based prevention.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library